migration and angiogenesis. 5, [11] [12] [13] Inhibition of OPN expression by small interfering (si) RNA in glioma cells reduces cell proliferation and motility in vitro and prevents cancer progression in vivo. [14] [15] [16] [17] [18] [19] Therefore, OPN is considered to be a therapeutic target in glioblastoma. 15 On the other hand, OPN induces migration of neutrophils 20 and macrophages, 5, 11 which is an activity that may counteract cancer. 6, [20] [21] [22] [23] [24] The aim of the present study was to establish (i) whether OPN gene over-expression is related to specific cancer types such as of breast, [25] [26] [27] prostate, [27] [28] [29] liver, 5, 30 head and neck 31 and brain 32 or whether it is a general phenomenon in cancer; (ii) OPN expression in the different grades of glioma; (iii) whether OPN expression promotes neutrophil and macrophage infiltration; and (iv) whether these effects on migrating cells are dependent on the RGD peptide sequence of OPN. 24, 33, 34 We found in silico that elevated OPN gene expression is a general phenomenon in cancer. In some types of cancers including glioblastoma, it is one of the highest expressed genes in a large percentage of patients. In glioma, OPN gene over-expression was found only in its most malignant state, glioblastoma. Moreover, we showed that OPN protein co-localizes with neutrophils and macrophages in glioblastoma. In vitro, we observed that the RGD sequence of OPN is necessary for recruitment of neutrophils.
Materials and methods

Neutrophil migration in vitro
Animal preparation: Eight-week-old adult OPN-null mice and their matched C57BL/6 J wild-type (WT) controls were used. The generation of these OPN-null mice has been previously described. 20, 35 The animals were killed by carbon dioxide exposure and cervical dislocation. All experiments were performed in duplicate and permission was granted by the Local Animal Committee.
Migration assays: Femurs and tibias of WT and OPN-null mice (n = 6 per mouse type) were dissected and bone marrow was flushed with 2Á5 ml a-minimum essential medium containing 10% fetal bovine serum and antibiotics (100 lg/ml penicillin G, 50 lg/ml gentamicin sulphate and 0Á3 lg/ml fungizone). After lysis of the red blood cells with E-lyse (Cardinal, Phoenix, AZ), cells were layered on a Percoll gradient (Sigma, Oakville, ON, Canada; 3 ml of 55% Percoll, top layer; 3 ml of 65% Percoll, middle layer; 4 ml of 80% Percoll, bottom layer) and centrifuged at 1500 g for 30 min at 10°. The interface between the 65% and 80% Percoll layers, which was enriched with neutrophils (> 90%), was collected. Typical yields were 2 · 10 7 to 3 · 10 7 neutrophils/mouse, of which > 98% were viable, as indicated by Trypan blue staining.
For quantification of neutrophil migration, 24-transwell chamber plates (Corning, Acton, MA) were used. Briefly, after sampling and centrifugation of the neutrophils, a neutrophil suspension of 1 · 10 6 cells/100 ll phosphate buffer was placed onto polycarbonate membrane inserts (3Á0-lm pore size; Sigma) coated with fetal bovine serum. The inserts were placed in the wells. Exogenous post-translationally-modified rodent macrophage OPN (mu-OPN; purified to homogeneity from RAW 264.7 cell-conditioned medium), full-length recombinant rat OPN (rec-OPN; produced as described previously; 36 Sigma), which lacks post-translational modifications, and mutated OPN (mut-OPN; Sigma), which lacks the RGD sequence, were used in migration assays.
Neutrophils were allowed to migrate for 60 min at 37°i n 5% CO 2 to attach to glass cover slips (12 mm diameter). The cover slips with the neutrophils attached were gently washed with 2Á0 ml PBS. The number of attached cells on each cover slip was counted (IMAGEJ SOFTWARE, developed by Wayne Rasband, http://rsbweb.nih.gov/ij/) in five fields of each of the two replicate wells using digital images captured with a time-lapse video microscope Eclipse E400 equipped with differential interference contrast optics and a · 40 objective (Nikon, Tokyo, Japan).
In silico analysis of OPN expression
The genome databases of Pubmed (http://www.ncbi.nlm. nih.gov/sites/entrez) were used to collect information on the human OPN gene such as Entrez Gene ID (6696), gene name (osteopontin), gene symbol (OPN) and gene synonyms (secreted phosphoprotein 1).
The Gene Expression Omnibus (http://www.ncbi.nlm.-nih.gov/geo/) and ArrayExpress (http://www.ebi.ac.uk/ microarray-as/ae/) collections were searched to retrieve published microarray gene expression data sets comparing cancer samples with normal tissue samples. Microarray expression data were retrieved from 35 data sets (after excluding 29 data sets for various reasons such as normal tissue samples consisting of cells in culture) comparing cancer with normal human samples. For all data sets, log 2 -transformed signal intensity measurements were available for each probe in every sample including probes for the OPN gene. The original method of spot qualification and data normalization was maintained for each data set. To compare between platforms, an expression intensity was calculated for each Entrez Gene ID by averaging multiple probe intensities. Hence, expression parameters, namely percentage over-expression (the fraction of patients in a data set that showed over-expression of the OPN gene) and percentile of fold change (the level of over-expression of the OPN gene expressed as a percentile of expression levels of all genes in a particular data set) were used to quantify the frequency and level of OPN gene expression. 37, 38 A percentile of fold change larger than 0Á95 was arbitrarily considered as substantial over-expression and a percentage over-expression larger than 30% was arbitrarily considered as frequent overexpression.
In situ analysis of OPN expression Histochemistry: Tissues samples were snap-frozen in liquid nitrogen in the operating room, and stored at )80°u ntil used. Cryostat sections (8-lm thick) were cut at )25°on an HM560 cryostat (MICROM, Walldorf, Germany), picked up on glass slides, and stored at )80°until used. All staining procedures including controls were performed on serial sections of each tissue sample. Haematoxylin & eosin staining was performed to check morphology.
Immunohistochemical staining of OPN, neutrophils and macrophages was performed on cryostat sections as described. 73, 74 An anti-human OPN rabbit monoclonal antibody (dilution, 1 : 600 in PBS; Vector Laboratories, La Jolla, CA), mouse monoclonal anti-human macrophage CD68 (clone EBM 11, isotype IgG1, kappa; dilution, 1 : 400 in PBS) and anti-neutrophil elastase (dilution, 1 : 400 in PBS; Dako, Glostrup, Denmark) were used as primary antibodies. Immunostaining was performed manually at room temperature. After washing with PBS, three times for 5 min, endogenous peroxidase and non-specific background staining were blocked with 0Á1% sodium azide, 0Á3% H 2 O 2 in PBS for 15 min. After washing with PBS, three times for 5 min, sections were incubated with the anti-OPN, anti-CD68 primary antibodies and anti-neutrophil elastase at the given dilutions for 60 min. After rinsing with PBS, three times for 5 min, sections were incubated with secondary goat anti-rabbit conjugated with peroxidase for OPN staining, with rabbit anti-mouse conjugated with peroxidase secondary for macrophages (1 : 50) and with Powervision goat antimouse antibodies for neutrophils (Immunologic, Duiven, the Netherlands). After rinsing with PBS, three times for 5 min, sections were incubated for 20 min with aminoethylcarbazole as peroxidase substrate. All samples were counterstained with haematoxylin for 20 seconds before mounting. Negative control incubations were performed in the absence of primary antibody.
Image analysis and semi-quantitative analysis
The OPN immunostained sections were analysed with the use of quantitative image analysis as described in detail elsewhere, 75 using a Vanox-T photomicroscope with a 10 · objective (Olympus, Tokyo, Japan) and a CFW-1312M 1360 · 1024 pixel 10-bit monochrome FireWire camera (Scion, Tucson, AZ) mounted on the front port of the Vanox using adapting optics. Sections were illuminated with white light that was filtered by a monochromatic filter of 480 nm and an infrared blocking filter to correctly measure the absorbance of the coloured peroxidase reaction product, oxidized aminoethylcarbazole, without interference of the counter-stain haematoxylin. Absorbance calibration of the images was performed with the use of a calibrated 10-step density tablet (Stouffer, South Bend, IN). After measuring the step tablet, known absorbance values were related to measured grey values using the built-in calibration function of IMAGEJ, using the Rodbard function. 75 Density calibrated images were recorded in one single run and stored on disk for analysis. The resolution used prevented distributional errors. All settings were maintained throughout the recording session and at the end of the session were verified against the step tablet values. 75 Software used for capturing was [76] [77] [78] The Kellgren and Lawrence scale is a general scoring system describing degrees of severity (0 = normal, 1 = doubtful, 2 = mild, 3 = moderate, 4 = severe). We have added one more degree 5 = very severe. Two observers (N.A.A. and C.J.F.V.N.) scored all sections together to obtain agreement on standards for grading in a training session. Afterwards, the two observers scored all sections again independently and in blinded fashion. Both scores were very similar; only for 10% of the sections, the score deviated by one scale at the most. These sections were then scored together to obtain a consensus score.
Data analysis
The R-PROGRAM (http://www.r-project.org/) was used to determine the distribution of numbers of cells in vitro. It appeared that log 10 conversion of the data resulted in normal distributions in all cases (Fig. S1) , allowing the use of the Student's t-test variant for the assumption for non-paired data with unequal variances (http://beheco. oxfordjournals.org/cgi/content/full/17/4/688) to determine significant differences (P 0Á05) in the proportion of cells that had migrated towards the chemotactic gradients after the addition of different types of exogenous OPN to WT and OPN )/) neutrophils. MATLAB (MatWorks, Natick, MA) was used for calculations, figures and tables. To compute and visualize in silico data (expression parameters for OPN) the R-PROGRAM, MATLAB and EXCEL 2007 were used. The same programs were used to determine semi-quantitative scoring of neutrophils and macrophages in brain tissue sections. The QQ-plot was used to determine association between normal distribution of OPN expression and presence of neutrophils and macrophages in situ. Again, the Student's t-test was used to determine significant differences (P 0Á05) between OPN expression in non-cancerous sections and glioblastoma sections. The general regression model was used in R-PROGRAM to analyse the linear relation between the amount of OPN protein and presence of neutrophils and between the amount of OPN protein and presence of macrophages in non-cancerous sections and glioblastoma sections.
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Results
RGD-dependent neutrophil migration in vitro
Migration of WT and OPN )/) neutrophils from mice was significantly different when stimulated with either mut-OPN lacking the RGD sequence or rec-OPN lacking post-translational modification or the post-translationally modified mu-OPN in vitro (Fig. 1) . In the presence of mut-OPN hardly any OPN )/) neutrophil migration occurred, whereas WT neutrophils with endogenous OPN expression migrated more. The effects of exogenous mu-OPN were weaker on recruitment of OPN )/) neutrophils than of WT neutrophils. Exogenous rec-OPN had the strongest effect on recruitment of both WT neutrophils and OPN )/) neutrophils. irrespective of the type of exogenous OPN used (P < 0Á05 in all cases). The major in vitro findings are that exogenous OPN-induced neutrophil migration is RGD dependent, that the endogenous OPN in neutrophils is pro-migratory and that rec-OPN without post-translational modification has the strongest effect on neutrophil migration.
In silico analysis of OPN expression in cancer
The OPN mRNA levels were in general high in the 35 data sets of the various tumour types investigated. In 20 out of 35 data sets, including glioblastoma, the OPN gene was over-expressed with both percentile fold change > 0Á95 and percentage over-expression > 30% (Fig. 2) . In some types of cancer, such as ovarian cancer, lung cancer and melanoma, the OPN gene was one of the highest expressed genes in almost all patients. In glioblastoma, the OPN gene was one of the 5% highest expressed genes in 90% of the patients when considering the Head&neck carcinoma (48) Gastric carcinoma (52) Ovarian carcinoma (42) Colon carcinoma (57) Colon carcinoma (70)
Bladder carcinoma (60) Lung carcinoma (54) Lung carcinoma (44) Lung carcinoma (43) Lung carcinoma (71)
Mamma carcinoma (64) Leiomyosarcoma (49) Glioblastoma (61) Non-seminoma (37) Thyroid carcinoma (72)
Gastric carcinoma (68) Seminoma (37) Melanoma (39) Mesothelioma ( microarray data set of Bredel et al. 61 . Analysis of the data set of Kotliarov et al. 63 , also showed high OPN gene expression in glioblastoma only and not in lower-grade glioma, but the percentage of patients with high expression was much lower. Figure 3 shows that OPN gene expression in glioma was highest in glioblastoma (WHO grade 4 and histological glioblastoma) and it was lower in low-grade and anaplastic glioma and in gliomas with astrocytic or oligodendroglial elements. These data indicate that OPN gene over-expression is a general phenomenon related to cancer and is grade dependent in glioma.
Relation between in situ OPN protein and the presence of neutrophils and macrophages Figure 4 shows localization of OPN protein, neutrophils and macrophages in normal brain tissue as detected immunohistochemically. In normal brain tissue, OPN protein expression (Fig. 4a) was low, whereas neutrophils (Fig. 4b) and macrophages (Fig. 4c) were absent. Localization of the OPN protein in normal brain was mainly intracellular in endothelial cells, microglia cells (Fig. 4a ) and a few neurons (not shown). 63 Figure 5 shows localization of OPN protein, neutrophils and macrophages in glioblastoma. The OPN protein in glioblastoma was mainly present extracellularly, and its level was highest around necrotic areas and in the vicinity of blood vessels. It was absent within necrotic areas (Fig. 5a,d,g ). Non-specific staining was found only in certain necrotic areas. Localization of neutrophils (Fig. 5-b ,e,h) and macrophages (Fig. 5g,f,i) in adjacent sections to the OPN-immunostained sections demonstrated that glioblastoma tissue was infiltrated with neutrophils and macrophages. Image analysis showed that OPN protein expression was significantly higher in glioblastoma (mean ± SD: 0Á07 ± 0Á02 in areas with low expression and mean ± SD: 0Á18 ± 0Á06 in areas with high expression; n = 13) than in normal brain (mean ± SD: 0Á03 ± 0Á01 in all areas; n = 5; P < 0Á05). Regression analysis of the OPN protein expression levels significantly related with the presence of neutrophils ( Fig. 6a ; P < 0Á05)) and macrophages ( Fig. 6b; P < 0Á05) ).
Discussion
Our in silico analysis enabled us to investigate 35 microarray data sets of various types of cancer, comparing OPN gene expression in cancer with that in control tissue. It appeared that the OPN gene is one of the most over-expressed genes in a wide variety of cancer types in a high percentage of patients, including glioblastoma. These data confirm previous reports that OPN gene expression is elevated in various types of human cancers including glioblastoma and its expression is malignancy related. 4, 27, [79] [80] [81] In situ, we found that OPN protein is present intracellularly in normal brain in endothelial cells, microglia cells and some neurons. This localization pattern was similar to that of vascular endothelial growth factor A (VEGF-A; data not shown). It is known that intracellular VEGF-A, particularly in neuronal cells, has cell protective effects. 82, 83 It has been implied that the transcription factor hypoxia inducible factor 1a (HIF-1a), which also drives OPN expression, 84 is responsible for intracellular expression of VEGF-A. 85 Levels of OPN protein in glioblastoma appeared to be distinctly elevated. Moreover, OPN protein was present extracellularly in glioblastoma samples. It is possible that hypoxia induced OPN over-expression in glioblastoma via HIF-1a because OPN protein was found abundantly around necrotic areas. Elevated OPN levels have been described in an experimental model of brain tumours in rats. 15, 86 It has also been reported that OPN is secreted in tumours into the extracellular matrix by cancer cells where it facilitates proliferation, motility and migration of cancer cells through binding to integrins and CD44. 15, 87, 88 It also induces secretion of matrix metalloproteases, which facilitate invasion of cancer cells. [89] [90] [91] Inhibition of OPN expression by siRNA in glioma cells not only reduced cell motility and cell proliferation in vitro but also down-regulated development of tumours in vivo. [14] [15] [16] [17] [18] [19] Therefore, OPN in glioblastoma is considered to be a therapeutic target. 15 However, this assumption has to be carefully considered because OPN may have an intracellular function in normal brain as a neuroprotectant. 82, 83 Furthermore, OPN is also directly related to the influx of white blood cells such as neutrophils and macrophages in glioblastoma in an RGD-dependent manner, which may have an anti-cancer effect.
We showed that intracellular OPN affects neutrophil migration in vitro. Migration of OPN )/) neutrophils in the presence of mut-OPN (lacking the RGD sequence) was almost completely absent, whereas WT neutrophils showed migration. This finding suggests that the integrinbinding peptide sequence (RGD) of OPN is necessary for neutrophil migration in vitro.
It is likely that the OPN RGD sequence interacts with integrins such as aVb3, a4b1 and a9b1.
12,92-103 The latter integrin is highly expressed by neutrophils 96 and macrophages. 24, 33, 34 It may also be possible that leucocyte influx in glioblastoma was not really altered by OPN, but rather efflux and apoptosis of leucocytes 33 was reduced. Accordingly, macrophages accumulate in infected brain as a result of elevated OPN levels 33 . The relevance of the influx of white blood cells in glioblastoma and its down-regulating effect on carcinogenesis is unknown. It has been found previously that activity of leucocytes is down-regulated in experimental tumours because cancer cells can secrete immune-down-regulating molecules such as a2-macroglobulin, prostaglandin E 2 and transforming growth factor-b. 74, 104 Nevertheless, the potential functioning of OPN in normal brain and the effects of OPN on migration of leucocytes into tumours and the anti-cancer effects of these cells have to be taken into consideration when using OPN as a therapeutic anti-cancer target.
It is concluded that (i) OPN gene over-expression is a general phenomenon in cancer according to the in silico microarray analysis; it is one of the highest expressed genes in various types of cancer in the majority of the patients, (ii) OPN gene over-expression is linked with malignancy in glioma, (iii) the RGD sequence in OPN is necessary for migration of neutrophils in vitro, and (iv) extracellular OPN protein expression co-localizes with neutrophils and macrophages in glioblastoma.
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